February 6, 2026

TrumpRx.gov launches with 43 products

TrumpRx.gov has launched with 43 products following agreements with pharmaceutical companies for most favoured nation pricing. TrumpRx is a U.S. government prescription drug website launched by the Trump administration in 2026. The goal is to help Americans find lower-cost prescription medications through direct pricing deals with pharmaceutical companies.

Number of products represented per company at launch:

  • Pfizer: 31
  • AstraZeneca: 4
  • EMD Serono: 3
  • Novo Nordisk: 3
  • Eli Lilly: 2

Track every
FDA Priority Review Voucher Program.

Stay updated
Thank you!
Oops! Something went wrong while submitting your email.
HomeHistoryNewsCRL DashboardCNPV DashboardContactPRV Watch Pro
Privacy PolicyTerms and Conditions
Copyright © 2026 PRV Watch

This webpage has been compiled from manually reviewing thousands of documents from the U.S. Securities and Exchange Commission (SEC), U.S. Food and Drug Administrations (FDA), Federal Register, press releases and financial records. The information on this page has been compiled from publicly available sources only and does not include any undisclosed PRV issuance's, transactions or redemptions.

Stay in the loop

News, analysis, and insights from the world of Priority Review Vouchers.

Thank you!
Oops! Something went wrong while submitting your email.